Taxim-O/Taxim-O 400: Usage in Pregnancy: Reproduction studies have been performed in mice and rats at doses up to 400 times the human dose and have revealed no evidence of harm to the fetus due to cefixime. There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Nursing Mothers: It is not known whether cefixime is excreted in human milk. Consideration should be given to discontinuing nursing temporarily during treatment with this drug.
Taxim-O Kids: Animal studies do not reveal a teratogenic effect. Very little drug is excreted in milk in the lactating animals. There is insufficient evidence of safety for use during human pregnancy.
The product should only be used during pregnancy or lactation if considered essential by the physician.